Ocata Therapeutics Inc fka OCAT

[carp1]

Here's the translation...

"Science" 2010, one of the hot spots predicted stem cell therapy
?Font: Big Middle Small? www.ebiotrade.com Time: December 18, 2009 Source: Bio-Link
-------------------------------------------------- -------------------------------------------------- --------------------------------


Abstract: Science Daily, "Science" magazine launched in 2009 breaking the occasion of the annual top ten are also a hot topic of science in 2010 were predicted, including stem cells, pluripotent stem cells to treat neurological diseases have been considered in the coming year will be a hot topic. Please follow the bio-pass editor recalled in 2009 the development track of the various stem cells to explore the stem cells next year to continue popular causes.


Science Daily, "Science" magazine launched in 2009 breaking the occasion of the annual top ten are also a hot topic of science in 2010 were predicted, including stem cells, pluripotent stem cells to treat neurological diseases have been considered in the coming year will be a hot topic. Please follow the bio-pass editor recalled in 2009 the development track of the various stem cells to explore the stem cells next year to continue popular causes.



The topic of stem cells in 2009 is absolutely hot, as in March this year, Obama gave an order to lift the ban on embryonic stem cell research, the U.S. life sciences term, scientists are eagerly preparing themselves to the full field of embryonic stem cells.
2009 Life Science Top Ten selection of innovative products, please vote!




Followed popular, in 2009, the U.S. FDA approved two cases of clinical trials of embryonic stem cells, albeit the first clinical trials of embryonic stem cells since suffered a bottleneck, but the second from the recent clinical trials of embryonic stem cells was approved and is being carried out in full swing .



The first clinical trials of embryonic stem cells

January 23, 2009, Geron announced, FDA has approved to carry out the world's first human embryonic stem cell therapy in clinical trials. Geron Corporation announced that it would then 8-10 with spinal injuries leading to paraplegia in patients with injections GRNOPC1. If successful, will conduct the clinical Phase III trial in the summer.



Geron's human embryonic stem cell products: GRNOPC1, a kind of nervous tissue from progenitor cells injected into the spinal cord is used to treat neurodegenerative diseases.



Currently, Geron's clinical trial was not carried out, not knowing what the reason for FDA continues to collect data on Geron's animal experiments.



A similar thing is occurring not only in the Geron Corporation, in February of this year, but also a disruption of neural stem cells in clinical trials. This is the FDA the results of a precaution, after all, too many unknown risks, only to have more evidence to go about carrying out human trials.



The second clinical trial of embryonic stem cells

November 18, Advanced Cell Technology (ACT) submitted to the FDA a human embryonic stem cells and application for phase II clinical trials.



This is the second world's first cases of human embryonic stem cells, clinical trials, blocked, the world's second case of human embryonic stem cells, clinical trials, recently approved by the U.S. FDA has formally launched a clinical trial.



ACT's embryonic stem cell clinical trial project is aimed at hereditary eye disease.



New Jersey project participants of the Macro Zarbin University School of Medicine, said the project I am cautious but optimistic. Compared with other experiments, the stem cells in the retina is relatively more likely to play a role.



Robert Lanza, chief scientist, according to ACT introduction, a previous animal experiments showed that using embryonic stem cells to treat Stargardt disease (a hereditary eye disease) are very effective, and there were no toxic side effects. This allows us to believe that human trials will be successful.



Poland, Casey Eye Institute will also participate in the clinical trials, the hospital, said Peter Francis, from the preliminary data from animal experiments to get a great deal of confidence that FDA has accepted our application in the information on next year approval of our clinical trials carried out for six months.



Bio-Link Comment: stem cells, regenerative medicine, these words in the next few years will become the most popular topic, but it allows people excited is finally out of the theoretical research laboratories, the clinical path of the. The significance of access to clinical trials, stem cell therapy closer to reality. No matter what difficulties the road, I believe that scientists will continue to move forward.

(Biological Tong Zhang Huan)

(http://www.ebiotrade.com/)








User Name: Password: